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filters following intra-operative cell salvage during cesarean
deliveryI. Fujioka,a Y. Ichikawa,a Y. Nakajima,b M. Kasahara,c M. Hattori,a T. Nemotoa
aDepartment of Obstetrics and Gynecology, Japanese Red Cross Shizuoka Hospital, Japan
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cDepartment of Clinical Pathology, Japanese Red Cross Shizuoka Hospital, JapanABSTRACTBackground: Intra-operative cell salvage is not routinely used during cesarean delivery because it is not cost-effective for patients
at low risk of hemorrhage and there are theoretical concerns about amniotic ﬂuid embolism. Some guidelines recommend using
leukocyte depletion ﬁlters to decrease the risk of amniotic ﬂuid embolism before re-infusing salvaged blood, but these ﬁlters are not
available in Japan. We compared the efﬁcacy and safety of leukocyte depletion and micro-aggregate ﬁlters in combination with
intra-operative cell salvage during cesarean delivery.
Methods: Blood was collected in a Cell Saver 5 reservoir during cesarean delivery. Four samples were collected: pre-wash, post-
wash, post-ﬁltration with a leukocyte depletion ﬁlter and post-ﬁltration with a micro-aggregate ﬁlter. Each sample was analyzed
for amniotic ﬂuid markers of zinc coproporphyrin-1 and sialyl-Tn, for fetal hemoglobin, and the sample underwent pathological
examination for white blood cells and squamous cells. Post-ﬁltration samples were compared using paired t-tests with P <0.05 indi-
cating statistical signiﬁcance.
Results: Zinc coproporphyrin-1 and sialyl-Tn were negative at almost all sample points. Squamous cells decreased by 59.1% post-
wash and 91.2% post-ﬁltration using a leukocyte depletion ﬁlter. Leukocyte depletion ﬁlters removed 99.7% of white blood cells
and were more effective in removing white blood cells than micro-aggregate ﬁlters (P=0.02).
Conclusion: Leucocyte depletion ﬁlters are more effective in removing white blood cells and squamous cells than micro-aggregate
ﬁlters, and their introduction for intra-operative cell salvage during cesarean delivery should be considered in Japanese clinical
practice.
 2019 Elsevier Ltd. All rights reserved.
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ﬁlterIntroduction
Allogenic and autologous blood transfusions have been
used for the treatment of severe obstetric hemorrhage
associated with placenta accreta, placenta previa, and
atonic bleeding. However, allogenic transfusion is asso-
ciated with the risk of infection and allergic reactions,
and there is a limit to the amount of autologous blood
that can be collected before delivery. Intra-operative cell
salvage (ICS), used in cardiovascular, orthopedic and
gynecological surgery, involves use of blood from the
bleeding site collected through a heparinised tube,
separation of cells by hemoconcentration, differentialAccepted July 2019
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in 1–2 L of 0.9% saline. Intra-operative cell salvage
removes circulating ﬁbrin, debris, plasma, leucocytes,
microaggregates, complement, platelets, free hemoglo-
bin, and most of the heparin.
Intra-operative cell salvage is rarely used in cesarean
delivery (CD) in Japan because leukocyte depletion ﬁl-
ters are not available and there is a theoretical concern
about amniotic ﬂuid embolism (AFE). If its safety can
be proven, it could be a useful management option in
patients at risk of massive hemorrhage.
According to the guidelines of the National Institute
for Health and Care Excellence (NICE)1 and the
National Health Service,2 ICS during CD is allowed.
There is no evidence of a direct relationship between
re-infusion of salvaged blood cells and the occurrencedepletion ﬁlters and micro-aggregate ﬁlters following intra-operative
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2 Efﬁciency of leukocyte depletion ﬁlters and micro-aggregate ﬁltersof AFE. The guidelines recommend the use of a leuko-
cyte depletion ﬁlter before re-infusing salvaged blood.
However, in Japan, leukocyte depletion ﬁlters are not
readily available due to low demand since allogenic
blood products are almost free of leukocytes at the pro-
duction phase.3 The ﬁlters were available between 2013
and 2016, but poor clinical demand prompted the man-
ufacturer to cease supply.
Instead, use of a micro-aggregate ﬁlter with a 10–
40 mm pore size during ICS and autologous blood trans-
fusion is recommended for removing micro-aggregate
impurities. To date, there have been no reports of
AFE with ICS during CD, when used with or without
a micro-aggregate ﬁlter.
The aim of this study was to evaluate the efﬁcacy and
safety of leukocyte depletion ﬁlters and micro-aggregate
ﬁlters by analyzing salvaged and ﬁltered blood compo-
nents from women undergoing CD. We hypothesized
that a micro-aggregate ﬁlter could be used instead of a
leukocyte depletion ﬁlter during ICS in cesarean
delivery.
Methods
After obtaining local research Ethics Committee
approval and written informed consent, the data of ﬁve
women who underwent elective CD between July 30,
2013 and August 18, 2013 were collected. Patients with
high fever, suspected intrauterine infection and/or emer-
gency CD due to the onset of labor or premature rup-
ture of membranes were excluded.
During surgery, ﬂuid (blood plus amniotic ﬂuid) was
aspirated from the abdomen immediately after rupture
of the membranes. The volume of amniotic ﬂuid was
estimated visually. The aspirated ﬂuid was collected in
the reservoir of a Cell Saver 5 (Hemonetics, Mas-
sachusetts, USA). Four samples were collected from
each patient:
Sample 1: pre wash (in the collecting reservoir)
Sample 2: post wash
Sample 3: post ﬁltration with a leukocyte depletion
ﬁlter (Pall RC100DJ)
Sample 4: post ﬁltration with a micro-aggregate ﬁlter
(Pall SQ40s)
Leukocyte depletion ﬁlters (Pall RC100DJ) are 8-
mm ﬁberglass ﬁlters. Micro-aggregate ﬁlters (Pall
SQ40s) can remove micro-aggregate cells larger than
40 mm.
Sample collection is shown in Fig. 1. All the samples
and circuits were shielded with aluminum foil to prevent
blood from resolving the zinc coproprphyrin-1 (ZnCP-1)
in response to light. Each sample was analysed for amni-
otic ﬂuid markers ZnCP-1, syalyl-Tn (STN), fetal hemo-
globin (HbF) (Kleihauer-Betke test), and underwentPlease cite this article in press as: Fujioka I et al. Eﬃciency of leukocyte
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(WBCs), squamous cells (SqCs), hair and meconium;
and Alcian blue stain).
Samples for ZnCP-1 were sent, completely shielded
with aluminum foil, to the Hamamatsu University
School of Medicine, where they were assayed using high
performance liquid chromatography.4 The normal value
is <1.6 (pmol/mL), and the sensitivity and speciﬁcity
for detecting AFE is 46% and 73% respectively.5
Samples for STN were assayed using competitive
radioimmunoassay. The lower limit of detection is
1.2 U/mL, where one unit is equivalent to 25 ng of
STN antigen. The sensitivity and the speciﬁcity for
detecting AFE is 26% and 97% respectively.5,6
HbF was analysed using the Kleihauer-Betke
method. For pathological examination, we made ﬁve
blood smear preparations of each sample, counted the
number of WBCs and SqCs under a microscope
(400) per mm2 and calculated the average of ﬁve slides.
When cells were observed, Alcian blue staining was per-
formed to determine whether they were fetal cells.
The removal rates for pathological examination were
calculated according to the following equations:
Removal rate 3 (%) = (Sample 2  Sample 3)/
Sample 2  100
Removal rate 4 (%) = (Sample 2  Sample 4)/
Sample 2  100
The results of samples 3 and 4, which are presented as
the numbers of WBC and squamous cells, were com-
pared using the paired t-test in the R statistical program-
ming language. A P-value of <0.05 indicated statistical
signiﬁcance.
Results
The characteristics of the ﬁve patients are summarized
in Table 1. The mean gestational age at delivery was
38 weeks and 2 days, mean volume of estimated blood
loss during CD was 422.6 (188–610) mL, mean volumedepletion ﬁlters and micro-aggregate ﬁlters following intra-operative
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Fig. 2 (a) Pre-wash. There were numerous white blood cells
(WBCs) and squamous cells. (b) Post-wash. There were some
WBCs. (c) Post-ﬁltration with leukocyte depletion ﬁlter. There
were few WBCs. (d) Post-ﬁltration with micro-aggregate ﬁlter.
There were some WBCs
Table 1 Characteristics and data of patients
Case Age G P Adaptation
of the CD
Gestational age
(W-D)
Blood
loos (mL)
Volume
of AF (mL)
Body weight
of newborn(g)
Duration of
surgery (min)
1 36 3 2 Previous CD 38–4 425 100 3000 50
2 32 1 0 Breech 38–1 490 NA 2118 32
3 40 2 1 Previous CD 38–3 400 200 3722 38
4 33 1 0 CPD 38–3 610 NA 2622 38
5 44 1 0 Breech 38–0 188 300 2814 29
Mean 37 1* 0* 38–2 422.6 200 2855.2 37.4
G: gravida. P: parity. AF: amniotic ﬂuid. CPD: cephalopelvic disproportion. NA: not applicable. CD: cesarean delivery. W-D: weeks-days.
*Values expressed as median.
I. Fujioka et al. 3of estimated amniotic ﬂuid was 200 mL, and mean body
weight of the babies was 2855 g. All operations were
completed in the routine manner and there were no
peri-operative complications.
The pathological results are shown in Figs. 2 and 3
and in Table 3. The median removal rates of SqCs and
WBCs after ﬁltration with a leukocyte depletion ﬁlter
were 91.2% and 99.7%, whereas those after ﬁltration
with a micro-aggregate ﬁlter were 2.2% and 20.3%,
respectively. Two patients had more SqCs and one had
more WBCs after ﬁltration with a micro-aggregate ﬁlter
than before ﬁltration. When the number of WBCs was
compared between samples 3 and 4, the P-value was
0.02 (95% conﬁdence interval; 135.9 to 17.1), indicat-
ing a statistically signiﬁcant difference (Fig. 4). Alcian
Blue staining, which reﬂects acid mucin in amniotic
ﬂuid, was negative in all samples after ﬁltration with
either ﬁlter (Fig. 3 and Table 4). Neither hair nor meco-
nium were found in any sample.
Table 2 shows the mean values of ZnCP-1, STN, and
HbF at each sample point in the ﬁve patients. ZnCP-1
levels were <1.6 pmol/mL at all sample points. Simi-
larly, STN levels were <10 U/mL in almost all samples,
except in sample 1. Fetal hemoglobin level increased in
some samples and decreased in others after ﬁltration
with the different ﬁlters, without trends.
Discussion
Leukocyte depletion ﬁlters (Pall RC100DJ) were more
effective at removing WBCs than micro-aggregate ﬁlters
(Pall SQ40s). In the pathological examination, SqCs
decreased by 82.7% in the post-wash stage and furtherTable 2 Mean values of ZnCP-1 and HbF
Test 1
ZnCP-1 (p mol/mL) <1.6
STN (U/mL) 510*
HbF (%)** 0.5
HbF: fetal hemoglobin. STN: sialyl-Tn. ZnCP-1: zinc coproporphyrin-1.
*Most cases are below the detection limit (10) except for case 1 (STN 12
**Values expressed as mean.
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leukocyte depletion ﬁlter. White blood cells decreased
by 99.7% in the post-ﬁltration stage using a leukocyte
depletion ﬁlter.2 3 4
<1.6 <1.6 <1.6
510 510 510
1.2 1.08 1.22
.7).
depletion ﬁlters and micro-aggregate ﬁlters following intra-operative
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Fig. 3 (a) Pre-wash Alcian blue (+). (b) Post-wash. (c) Post-
ﬁltration with leukocyte depletion ﬁlter. (d) Post-ﬁltration with
micro-aggregate ﬁlter. (b–d): Alcian blue (). (For interpreta-
tion of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article)
4 Efﬁciency of leukocyte depletion ﬁlters and micro-aggregate ﬁltersLeukocyte depletion ﬁlters (Pall RC100DJ) are
8-mm ﬁberglass ﬁlters that act through a combination
of passive sieving and active adhesion to a negative
surface charge.7,8 They can remove WBCs, fetal SqCs,
trophoblastic cells and activated neutrophils. Micro-
aggregate ﬁlters (Pall SQ40s) can remove micro-
aggregate cells larger than 20–40 mm. The diameter of
red blood cells, WBCs, platelets and SqCs (on the sur-
face) are 6–9 mm, 6–10 mm, 2–4 mm and 50–60 mm
respectively.7 Theoretically, micro-aggregate ﬁltersTable 3 Results of pathological examination of count per m
Case SqC 1 SqC 2 SqC 3
1 48.2 1.2 0.4
2 15 6.8 1.2
3 11.6 37.2 0
4 1.8 0 0
5 40.2 2.6 0
Median 15 2.6 0
Case WBC 1 WBC 2 WBC 3
1 9.4 89 0
2 112.8 223.4 0.6
3 8.8 85.6 0.2
4 161.2 81.4 1.2
5 12.4 16 0.2
Median 12.4 85.6 0.2
*Removal rate 3 (%)=(Sample 2  Sample 3)/Sample 2  100.**Removal r
cells. SqC: squamous cells. NA: not applicable.
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to remove SqCs.
Catling et al. found fetal SqC contamination in half
of the post-ﬁltration samples with ICS and a leucocyte
depletion ﬁlter (Pall RC100DJ).9 In contrast, other
studies showed almost no SqCs post ﬁltration with
ICS and a leucocyte ﬁlter (LeukoGuard RS),10 and
the same ﬁlter alone can remove components of pure
amniotic ﬂuid.7 Filtration had no effect either on the
concentrations of a-fetoprotein, tissue factor, or
endotherin-1, nor on the presence of meconium or ver-
nix, however lamellar bodies and fetal SqCs (ﬁltration
efﬁcacy 96.6% and 99.9%, respectively) and hair were
completely removed. The different results, in various
reports, regarding removal of SqCs seem to be related
to the use of different types of leukocyte depletion ﬁlters
used in the studies. 10
A leucocyte depletion ﬁlter is recommended during
ICS and can decrease the risk of adverse events such
as fever, rash, or itching.1 Leucocyte depletion ﬁlters
should be used during ICS for blood transfusion based
on the results of these studies, and the LeukoGuard
RS ﬁlter removes the SqCs more effectively than the
RC100DJ ﬁlter.
Amniotic ﬂuid embolism is an anaphylactoid
response involving endogenous mediator release follow-
ing exposure of the maternal circulation to small
amounts of amniotic ﬂuid. There is no standard
diagnostic test to conﬁrm the presence of AFE, but
ZnCP-1 and STN are considered useful markers for its
diagnosis.11 Both ZnCP-1 and STN markers were unde-
tectable in almost all samples even at pre-wash. Few
case reports have shown low levels of ZnCP-1 and
STN in post-wash materials during ICS or in normal
amniotic ﬂuid, so we focused on these markers in this
study. Blood contaminated with amniotic ﬂuid was col-
lected to compare the efﬁciency of removal of fetal com-
ponents for the two different ﬁlters. We anticipated thatm2 of squamous cells (SqC) and white blood cells (WBC)
SqC 4 Removal rate 3* Removal rate 4**
1.8 66.6 50
2 82.4 70.6
20.2 100 45.7
0.8 NA NA
7.6 100 192.3
2 91.2 2.2
WBC 4 Removal rate 3* Removal rate 4**
35.2 100 60.4
124.4 99.7 44.3
68.2 99.8 20.3
129.6 98.5 59.2
27.2 98.8 70
68.2 99.7 20.3
ate 4 (%)=(Sample 2  Sample 4)/Sample 2  100.; WBC: white blood
depletion ﬁlters and micro-aggregate ﬁlters following intra-operative
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Fig. 4 Results of pathological examination and comparison of post-ﬁltration sample 3 with sample 4. WBC: white blood cells.
*P=0.128, **P=0.02
Table 4 Pathological examinations of Alcian blue
Case 1 2 3 4
1 +   
2 +   
3  +  
4    
5 + +  
I. Fujioka et al. 5ZnCP-1 and STN might be detected in sample 1 and
then removed after washing (sample 2), but the levels
found in almost all samples were too low to permit an
assessment of removal efﬁciency.
ZnCP-1 is not only detected in meconium-
contaminated amniotic ﬂuid but also in uncontaminated
amniotic ﬂuid.12 Although it was unclear why ZnCP-1
and STN were negative in this study, these markers
might not be detected in elective CD patients whose
babies tend to experience less stress.
We could not identify any trends in HbF measure-
ments. In healthy pregnant women, the proportion of
HbF is 0.71 ± 0.51% (non-pregnant women: 0.28
± 0.35%).13 We found no difference between the levels
of HbF detected in this study and those reported in
pregnant women in general, which conﬁrms earlier ﬁnd-
ings.9,10 It is difﬁcult to distinguish fetal red blood cells
from maternal red blood cells during ICS,10 and, when
salvaged blood product is re-infused into the mother,
fetal blood is entrained into the maternal circulation.9,13
Fetal hemoglobin is less liable to cause embolism and
allergic reactions leading to AFE. Except in the case
of rhesus incompatibility, HbF contamination of mater-
nal blood is not a signiﬁcant issue in clinical practice.11
Morikawa et al. reported 50 cases of ICS performed
in Japan.14 There were no complications, including
AFE or hypotension, associated with ICS blood transfu-
sion using a leucocyte depletion ﬁlter. Intra-operative
cell salvage may have contributed to the avoidance of
allogeneic blood transfusion and to a reduction in thePlease cite this article in press as: Fujioka I et al. Eﬃciency of leukocyte
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who undergo ICS.
The SALVO study reported 1498 patients who were
randomised to receive ICS during CD.15 Leucocyte
depletion ﬁlters were used in only 54.9% (782/1498) of
the cases because of acute hypotensive events.15,16
Although it is difﬁcult to completely remove fetal com-
ponents using ICS with or without a leucocyte depletion
ﬁlter, there have been no reports of AFE occurring when
re-infusing salvaged blood.17 Some authors do not rec-
ommend routine use of leucocyte depletion ﬁlters in
obstetric practice. 16,18 Further research would be
required to reveal whether ﬁltration is needed to make
ICS safer during CD.
The study has limitations. First, the number of the
participants and tested markers were small due to lim-
ited research funding, so the ﬁndings must be viewed
with caution. In contrast, other studies have included
larger sample sizes and more markers.4,6,13
Second, the estimated mean amniotic ﬂuid volume
(200 mL) was low in our study compared with other
publications.19,20 The volume was estimated visually just
after rupture of the membranes and has the potential for
inaccuracy.
Thirdly, and importantly, the inconsistent volume of
cells seen on pathological examination remains unex-
plained, especially when using a micro-aggregate ﬁlter.
This might have resulted from artifacts introduced when
preparing the slides or from measurement errors. Such
sample handling errors may limit interpretation and
applicability of the ﬁndings, and mean the results must
be viewed with caution.
In conclusion, the AFE markers ZnCP-1 and STN
were negative in pre-wash samples at almost all sample
points in this study. Leucocyte depletion ﬁlters appear
more effective at removing WBCs and SqCs than
micro-aggregate ﬁlters. Introduction of leucocyte deple-
tion ﬁlters in Japanese clinical practice for ICS during
CD should be considered.depletion ﬁlters and micro-aggregate ﬁlters following intra-operative
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